Literature DB >> 16604308

Screening for cognitive impairment in Parkinson's disease--which marker relates to disease severity?

M W Riepe1, J Kassubek, F Tracik, G Ebersbach.   

Abstract

The frequency and pattern of cognitive deficits in Parkinson's disease (PD) is under discussion. We assessed 157 consecutive subjects with PD (66.4 +/- 8.9 years (mean +/- standard deviation); average duration of disease 3.5 +/- 1.3 years; average Hoehn and Yahr stage 2.4 +/- 0.9) diagnosed in centers specialized for the diagnosis and treatment of PD with brief tests for memory (Memory Impairment Screen), attention (Letter Sorting Test) and semantic fluency (category animals). Impaired memory was observed in about one half of the subjects regardless of severity of disease as assessed by staging according to Hoehn and Yahr. With greater severity, free recall was impaired and subjects required the cues to recall the items. Performance in the Letter Sorting Test and the semantic fluency task declined with increasing Hoehn and Yahr stage, also. We conclude that cognitive deficits are frequent in PD. Further analyses reveal that even in selected screening tests (e.g. semantic fluency) a significant impairment with increasing disease severity (Hoehn and Yahr stage) as opposed to disease duration alone can be demonstrated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16604308     DOI: 10.1007/s00702-006-0433-6

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  26 in total

1.  An estimate of the prevalence of dementia in idiopathic Parkinson's disease.

Authors:  R Mayeux; Y Stern; R Rosenstein; K Marder; A Hauser; L Cote; S Fahn
Journal:  Arch Neurol       Date:  1988-03

2.  Recall and recognition memory in Parkinson's disease.

Authors:  E K Breen
Journal:  Cortex       Date:  1993-03       Impact factor: 4.027

3.  Cognitive impairments in advanced PD without dementia.

Authors:  J Green; W M McDonald; J L Vitek; M Evatt; A Freeman; M Haber; R A E Bakay; S Triche; B Sirockman; M R DeLong
Journal:  Neurology       Date:  2002-11-12       Impact factor: 9.910

4.  Verbal working memory deficit in Parkinson's disease subjects.

Authors:  A M Graceffa; G A Carlesimo; A Peppe; C Caltagirone
Journal:  Eur Neurol       Date:  1999       Impact factor: 1.710

5.  Evidence for impaired encoding and retrieval memory profiles in Parkinson disease.

Authors:  Daniel Weintraub; Paul J Moberg; William C Culbertson; John E Duda; Matthew B Stern
Journal:  Cogn Behav Neurol       Date:  2004-12       Impact factor: 1.600

Review 6.  Cognitive and behavioral dysfunction in Parkinson's disease: neurochemical and clinicopathological contributions.

Authors:  D J Zgaljardic; N S Foldi; J C Borod
Journal:  J Neural Transm (Vienna)       Date:  2004-07-07       Impact factor: 3.575

7.  Screening for cognitive impairment in patients with acute stroke.

Authors:  Matthias W Riepe; Silke Riss; Daniel Bittner; Roman Huber
Journal:  Dement Geriatr Cogn Disord       Date:  2003-10-13       Impact factor: 2.959

8.  A longitudinal study of neuropsychological change in individuals with Parkinson's disease.

Authors:  Tamiko Azuma; Robyn F Cruz; Kathryn A Bayles; Cheryl K Tomoeda; E B Montgomery
Journal:  Int J Geriatr Psychiatry       Date:  2003-12       Impact factor: 3.485

9.  How common is dementia in Parkinson's disease?

Authors:  R G Brown; C D Marsden
Journal:  Lancet       Date:  1984-12-01       Impact factor: 79.321

Review 10.  The functional neuroanatomy of episodic memory: the role of the frontal lobes, the hippocampal formation, and other areas.

Authors:  B Desgranges; J C Baron; F Eustache
Journal:  Neuroimage       Date:  1998-08       Impact factor: 6.556

View more
  3 in total

Review 1.  MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.

Authors:  Irene Litvan; Dag Aarsland; Charles H Adler; Jennifer G Goldman; Jaime Kulisevsky; Brit Mollenhauer; Maria C Rodriguez-Oroz; Alexander I Tröster; Daniel Weintraub
Journal:  Mov Disord       Date:  2011-06-09       Impact factor: 10.338

Review 2.  Biomarkers in Parkinson's disease.

Authors:  John C Morgan; Shyamal H Mehta; Kapil D Sethi
Journal:  Curr Neurol Neurosci Rep       Date:  2010-11       Impact factor: 5.081

3.  Cognitive profiles in Parkinson's disease and their relation to dementia: a data-driven approach.

Authors:  Inga Liepelt-Scarfone; Susanne Gräber; Monika Fruhmann Berger; Anne Feseker; Gülsüm Baysal; Ilona Csoti; Jana Godau; Alexandra Gaenslen; Heiko Huber; Karin Srulijes; Kathrin Brockmann; Daniela Berg
Journal:  Int J Alzheimers Dis       Date:  2012-10-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.